Clinical Trials

Showing trials with last updates posted in 2025.

NCT03192436 | RECRUITING | NA
80 Participants

Electrophysiological Source Imaging Guided Transcranial Focused Ultrasound

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2018-09-01
Completion: 2030-06-30
Conditions
Healthy
Interventions
DEVICE
No Results Yet
NCT03113500 | ACTIVE_NOT_RECRUITING | PHASE2
48 Participants

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2017-05-25
Completion: 2021-07-16
Conditions
Adult T-Cell Leukemia/Lymphoma Anaplastic Large Cell Lymphoma, ALK-Negative Anaplastic Large Cell Lymphoma, ALK-Positive Angioimmunoblastic T-Cell Lymphoma Ann Arbor Stage II Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Anaplastic Large Cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Hepatosplenic T-Cell Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Peripheral T-Cell Lymphoma, Not Otherwise Specified
Interventions
DRUG OTHER
NCT03109288 | RECRUITING | PHASE1/PHASE2
250 Participants

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2017-08-11
Completion: 2026-01-01
Conditions
Multiple Sclerosis
Interventions
DRUG
No Results Yet
NCT03049462 | RECRUITING | PHASE1
100 Participants

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2017-03-13
Completion: 2026-09-30
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG OTHER
No Results Yet
NCT02997254 | RECRUITING
1000 Participants

COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2016-12-01
Completion: 2026-12-31
Conditions
Atrial Fibrillation Abnormal Heart Rhythms
No Results Yet
NCT02939300 | COMPLETED | PHASE2
18 Participants

Ipilimumab and Nivolumab in Leptomeningeal Metastases

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2018-02-15
Completion: 2021-07-22
Conditions
Leptomeningeal Carcinomatosis
Interventions
DRUG
NCT02936102 | TERMINATED | PHASE1
154 Participants

A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-10-20
Completion: 2024-11-22
Conditions
Advanced Solid Tumors Triple Negative Breast Cancer Chordoma and Alveolar Soft Part Sarcoma
Interventions
DRUG
No Results Yet
NCT02928289 | TERMINATED | NA
29 Participants

Safety and Effectiveness of the Sight Sciences VISCOโ„ข360 Versus SLT in Primary Open Angle Glaucoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2017-01-23
Completion: 2019-01-17
Conditions
Open-Angle Glaucoma
Interventions
DEVICE
NCT02910557 | ACTIVE_NOT_RECRUITING
187 Participants

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGICยฎ to Characterize Risk of Herpetic Infection

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2017-08-10
Completion: 2026-01-30
Conditions
Melanoma Herpetic Infection
No Results Yet
NCT02827877 | ACTIVE_NOT_RECRUITING | PHASE2
18 Participants

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-07-15
Completion: 2020-07-02
Conditions
HER2 Positive Breast Carcinoma Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer
Interventions
RADIATION OTHER BIOLOGICAL PROCEDURE
NCT02686528 | COMPLETED | NA
1133 Participants

Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-01-31
Completion: 2025-07-21
Conditions
Osteoarthritis Degenerative Joint Disease
Interventions
OTHER
No Results Yet
NCT02641145 | RECRUITING | NA
171 Participants

Molecular Imaging of Primary Amyloid Cardiomyopathy

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-04-01
Completion: 2027-12-31
Conditions
Amyloidosis, Primary Cardiomyopathy
Interventions
RADIATION DEVICE
No Results Yet
NCT02625961 | ACTIVE_NOT_RECRUITING | PHASE2
320 Participants

Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-02-10
Completion: 2025-11-15
Conditions
Bladder Cancer
Interventions
BIOLOGICAL
No Results Yet
NCT02544022 | RECRUITING
476 Participants

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2015-11-13
Completion: 2026-06-30
Conditions
Neurofibromatosis 1 Plexiform Neurofibromas
No Results Yet
NCT02522611 | NOT_YET_RECRUITING | PHASE1/PHASE2
30 Participants

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2025-11-19
Completion: 2026-12-01
Conditions
Intractable Pain Palliative Care
Interventions
DRUG
No Results Yet
NCT02515383 | ACTIVE_NOT_RECRUITING
41 Participants

Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2016-11-09
Completion: 2026-04-30
Conditions
Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm
Interventions
OTHER
No Results Yet
NCT02471352 | RECRUITING
700 Participants

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2015-06-19
Completion: 2027-01-31
Conditions
Dermatologic Conditions Healthy Volunteers Normal Volunteers Carcinoma, Merkel Cell
No Results Yet
NCT02462889 | COMPLETED | PHASE2
128 Participants

IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2015-06-30
Completion: 2019-03-31
Conditions
Age-Related Macular Degeneration
Interventions
DRUG
NCT02439775 | COMPLETED | NA
337 Participants

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyralโ„ข Multi-electrode Renal Denervation System

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2015-07-22
Completion: 2022-08-18
Conditions
Hypertension Vascular Diseases Cardiovascular Diseases
Interventions
DEVICE PROCEDURE
NCT02339571 | RECRUITING | PHASE2/PHASE3
600 Participants

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2015-11-23
Completion: 2033-06-30
Conditions
Stage III Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
PROCEDURE BIOLOGICAL
No Results Yet
NCT02315521 | RECRUITING
50 Participants

Standardized Prenatal Clinical Care for LUTO

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2014-12-31
Completion: 2026-11-30
Conditions
Urethral Obstruction
Interventions
PROCEDURE
No Results Yet
NCT02293954 | ACTIVE_NOT_RECRUITING | NA
20 Participants

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2015-11-11
Completion: 2022-03-06
Conditions
Breast Cancer Colon Cancer Extrahepatic Bile Duct Cancer Gallbladder Cancer Gastrointestinal Cancer Liver and Intrahepatic Biliary Tract Cancer Lung Cancer Metastatic Cancer Pancreatic Cancer Rectal Cancer Thyroid Gland Medullary Carcinoma Unspecified Adult Solid Tumor, Protocol Specific
Interventions
PROCEDURE OTHER DRUG
NCT02277444 | COMPLETED | PHASE3
130 Participants
NCT02192359 | ACTIVE_NOT_RECRUITING | PHASE1
18 Participants

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2016-03-07
Completion: 2022-02-21
Conditions
Recurrent Anaplastic Astrocytoma Recurrent Anaplastic Oligoastrocytoma Recurrent Anaplastic Oligodendroglioma Recurrent Glioblastoma Recurrent Gliosarcoma Recurrent Malignant Glioma Recurrent WHO Grade III Glioma
Interventions
BIOLOGICAL DRUG OTHER
NCT02050347 | ACTIVE_NOT_RECRUITING | PHASE1
7 Participants

Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2014-04-30
Completion: 2019-10-31
Conditions
Non-Hodgkin's Lymphoma B-Cell ALL B-Cell CLL
Interventions
GENETIC
No Results Yet
NCT01885689 | ACTIVE_NOT_RECRUITING | PHASE2
72 Participants

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2014-02-10
Completion: 2019-12-27
Conditions
Adult Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Therapy-Related Myelodysplastic Syndrome
Interventions
DRUG PROCEDURE OTHER
NCT01843374 | ACTIVE_NOT_RECRUITING | PHASE2
571 Participants

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2013-05-17
Completion: 2016-01-24
Conditions
Unresectable Pleural or Peritoneal Malignant Mesothelioma
Interventions
DRUG
NCT01810913 | RECRUITING | PHASE2/PHASE3
613 Participants

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2013-03-22
Completion: 2027-01-01
Conditions
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
Interventions
DRUG PROCEDURE BIOLOGICAL RADIATION OTHER
No Results Yet
NCT01788839 | RECRUITING
475 Participants

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2013-02-28
Completion: 2026-02-28
Conditions
Breast Cancer Lymphoma Hodgkin's Lymphoma
Interventions
BEHAVIORAL OTHER DEVICE
No Results Yet
NCT01776398 | RECRUITING
2000 Participants

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2012-08-29
Completion: 2027-12-31
Conditions
Chronic Obstructive Pulmonary Disease (COPD) Smoking Smoking Cessation Idiopathic Pulmonary Fibrosis (IPF) Rheumatoid Arthritis-Associated Interstitial Lung Disease Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)
No Results Yet
NCT01702805 | COMPLETED | NA
1824 Participants

Transfusion of Prematures Trial

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2012-12-31
Completion: 2020-01-31
Conditions
Infant, Newborn, Diseases Infant, Extremely Low Birth Weight Infant, Small for Gestational Age Bronchopulmonary Dysplasia (BPD) Anemia
Interventions
PROCEDURE
NCT01631617 | RECRUITING | PHASE2
130 Participants

Effects of Treatments on Atopic Dermatitis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2012-09-18
Completion: 2027-01-01
Conditions
Eczema Dermatitis Skin Diseases, Genetic Dermatitis, Atopic Skin Diseases
Interventions
DRUG OTHER
No Results Yet
NCT01591707 | ACTIVE_NOT_RECRUITING | NA
700 Participants

Evaluating a Social and Communication Intervention for Preschoolers

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2012-07-31
Completion: 2026-02-28
Conditions
Autism Spectrum Disorder
Interventions
BEHAVIORAL
No Results Yet
NCT01575548 | ACTIVE_NOT_RECRUITING | PHASE3
129 Participants

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2012-08-08
Completion: 2018-07-17
Conditions
Clear Cell Renal Cell Carcinoma Stage IV Renal Cell Cancer AJCC v7
Interventions
PROCEDURE DRUG OTHER
NCT01473004 | COMPLETED | PHASE2
48 Participants

SIR-Spheresยฎ 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2011-10-31
Completion: 2022-07-07
Conditions
Stage IV Uveal Melanoma
Interventions
DEVICE
NCT01422694 | RECRUITING
2000 Participants

Natural History and Development of Spondyloarthritis

Study Type: OBSERVATIONAL
Last Updated: 2025-11-14
Start Date: 2011-08-12
Conditions
Arthritis Spondylitis, Ankylosing
No Results Yet
NCT01386385 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
53 Participants

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2011-06-20
Completion: 2019-05-26
Conditions
Lung Adenocarcinoma Lung Adenocarcinoma, Mixed Subtype Lung Large Cell Carcinoma Lung Squamous Cell Carcinoma Minimally Invasive Lung Adenocarcinoma Stage III Lung Non-Small Cell Cancer AJCC v7 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Interventions
RADIATION DRUG OTHER
NCT01327781 | ACTIVE_NOT_RECRUITING | PHASE1
62 Participants

Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2011-03-25
Completion: 2017-03-05
Conditions
HER2/Neu Positive Recurrent Breast Carcinoma Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
Interventions
DRUG OTHER
No Results Yet
NCT01167712 | ACTIVE_NOT_RECRUITING | PHASE3
692 Participants

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2010-09-27
Completion: 2015-12-01
Conditions
Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Transitional Cell Carcinoma Ovarian Brenner Tumor Ovarian Clear Cell Adenocarcinofibroma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Carcinoma Ovarian Undifferentiated Carcinoma Primary Peritoneal Serous Adenocarcinoma Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIC Ovarian Cancer AJCC v6 and v7 Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
BIOLOGICAL DRUG PROCEDURE
NCT01139970 | ACTIVE_NOT_RECRUITING | PHASE1
66 Participants

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-14
Start Date: 2010-05-21
Completion: 2014-03-21
Conditions
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult T Acute Lymphoblastic Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia
Interventions
OTHER DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 107903 trials